Small Molecules
Total Trials
47
As Lead Sponsor
40
As Collaborator
7
Total Enrollment
2,484
NCT01682577
Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition
Phase: N/A
Role: Lead Sponsor
Start: Sep 30, 2008
Completion: Dec 31, 2008
NCT01006785
Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer
Phase: Phase 2
Start: Aug 31, 2009
Completion: Mar 31, 2012
NCT01005069
Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus
Start: Oct 31, 2009
Completion: Aug 31, 2010
NCT01677260
Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet
Completion: Jan 31, 2010
NCT01677247
Bioequivalence Study of 4 mg Glimepiride Tablet
Start: Feb 28, 2011
Completion: Mar 31, 2011
NCT01378585
Safety and Efficacy of DLBS1033 in Healthy Subjects
Start: May 31, 2011
Completion: Jul 31, 2011
NCT01433562
Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients
Phase: Phase 2/3
Start: Aug 31, 2011
Completion: Nov 30, 2012
NCT01472614
Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus
Phase: Phase 3
Start: Sep 30, 2011
Completion: Apr 30, 2013
NCT01531933
Efficacy and Safety of DLBS3233 in Prediabetic Patients
Start: Nov 30, 2011
Completion: Jul 31, 2012
NCT01573403
Efficacy and Safety of DLBS2411 in Healthy Volunteers
Phase: Phase 1/2
Start: Apr 30, 2012
Completion: Jan 31, 2013
NCT01790997
Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
Start: May 31, 2012
Completion: Dec 31, 2013
NCT01645332
Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus
Start: Jul 31, 2012
Completion: Sep 30, 2014
NCT01694537
The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers
Role: Collaborator
Completion: Dec 31, 2012
NCT01936012
Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition
Start: Feb 28, 2013
Completion: Feb 28, 2013
NCT01733459
Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
Start: Mar 31, 2013
Completion: Jun 30, 2018
NCT01865474
Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus
Phase: Phase 4
Start: May 31, 2013
Completion: Jun 30, 2016
NCT02518451
Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg
Start: Jun 30, 2013
Completion: Mar 31, 2014
NCT01905878
Biological Half Life of DLBS1033 in Healthy Volunteers
NCT02233777
Bioequivalence Study of Two Formulations of Pregabalin Capsules 150 mg
Start: Jun 30, 2014
Completion: Jun 30, 2014
NCT01999686
PCOS Treatment Using DLBS3233, Metformin, and Combination of Both
Start: Oct 31, 2014
Completion: May 31, 2019
NCT02262169
DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers
Completion: Mar 31, 2019
NCT02362984
DLBS1033 for the Treatment of Acute Ischemic Stroke
Completion: Apr 30, 2017
NCT02133521
DLBS1033 for Acute Ischemic Stroke Patients
Start: Nov 11, 2014
Completion: Apr 21, 2023
NCT02660060
Bioequivalence Study of Two Formulations of Pramipexole Tablets 0.25 mg
Start: May 31, 2015
Completion: Jun 30, 2015
NCT02145988
DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease
Start: Jun 3, 2015
Completion: Jul 31, 2018
NCT01942122
DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis
Start: Oct 31, 2015
Completion: Apr 30, 2021
NCT02146664
DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization
Start: Nov 30, 2015
Completion: Mar 31, 2018
NCT03422575
Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets
Start: Dec 31, 2015
Completion: Mar 31, 2016
NCT01972477
DLBS1449 in Diabetic Patients With Low HDL
Start: Jul 31, 2016
Completion: Jan 31, 2018
NCT02976701
Effect of DLBS1033 After Primary PCI in Patients With STE-ACS
Start: Nov 30, 2016
Completion: Mar 31, 2023
NCT03367195
Efficacy and Safety of DLBS2411 in the Management of GERD
Start: Aug 16, 2018
Completion: Sep 9, 2020
NCT06817811
Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet
Phase: Phase 1
Start: Apr 15, 2021
Completion: Jun 3, 2021
NCT05248802
DLBS2411 Treatment For Functional Dyspepsia
Start: Dec 9, 2022
Completion: Aug 31, 2025
NCT06127212
Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablets
Start: Mar 8, 2023
Completion: May 6, 2023
NCT06127225
Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)
Start: Apr 28, 2023
Completion: Aug 28, 2024
NCT06558058
Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets
Start: Jun 8, 2023
Completion: Aug 29, 2023
NCT06558045
Bioequivalence Study of Rivaroxaban 20 mg Film-coated Tablets
Start: Jul 6, 2023
Completion: Oct 2, 2023
NCT06558032
Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film-coated Tablets
Start: Nov 6, 2023
Completion: Feb 7, 2024
NCT06100432
Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ Β-carotene) for Infertile Males
Start: Nov 11, 2023
Completion: Oct 31, 2025
NCT06525155
Effect GnRH Agonist Administration in Endometriosis Cyst Patients
Start: Jan 2, 2024
Completion: Feb 28, 2025
NCT07075289
Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo
Start: Apr 1, 2024
Completion: Dec 27, 2024
NCT06558006
Safety and Efficacy Predimenol for Headache
Start: Jun 19, 2024
Completion: Oct 15, 2024
NCT06497439
Efficacy and Safety of Silfamin for Common Cold
Start: Jul 12, 2024
Completion: Sep 30, 2024
NCT06510257
Safety and Efficacy Reconyl for Cough With/Without Sore Throat
Start: Jul 23, 2024
Completion: Oct 3, 2024
NCT06558071
Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers
Start: Oct 21, 2024
Completion: Jun 30, 2025
NCT06933862
Effects of Channa Striata Extract on Intestinal Inflammation and Nutritional Status in Malnutritional Toddlers After Albendazole Therapy in South Bangka District
Start: May 15, 2025
Completion: Jun 30, 2026
NCT07089329
Efficacy of Striatin in Malnourished Children
Start: May 20, 2025
Completion: Oct 1, 2025
Loading map...